**   **Number of studies**   **Participants**   **Statistical methods**   **SMD(00%CI)**                                            **Heterogeneity**                  -------------------------------------- ----------------------- ------------------ ------------------------- --------------------------------------------------------- ------------------- ----------- -----   Serofast group *vs* healthy group      0                       000                SMD(IV, REM, 00% CI)      0.00(0.00, 0.00) ^[\*](#TFN0){ref-type="table-fn"}^       00.00               \<0.00000   00%   Serofast group *vs* serological cure   0                       000                SMD(IV, REM, 00% CI)      0.00 (0.00, 0.00) ^[\*](#TFN0){ref-type="table-fn"}^      00.00               \<0.00000   00%   Serological cure *vs* healthy group    0                       000                SMD(IV, FEM, 00% CI)      0.00(−000, 0.00)                                          0.00                0.00        0   IL-00                                                                                                                                                                                                    Serofast group *vs* healthy group      0                       000                SMD (IV, FEM, 00% CI)     −0.00 (−0.00, 0.00)                                       0.00                0.00        00%   IL-00                                                                                                                                                                                                    Serofast group *vs* healthy group      0                       000                SMD (IV, FEM, 00% CI)     −0.00(−0.00, −0.00) ^[\*](#TFN0){ref-type="table-fn"}^   